Atara Biotherapeutics Inc (ATRA)

Atara Biotherapeutics Inc Azioni (ATRA) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	123.41% 2.138	0.957	1.226	0.221	4.459
Operating Expenses	0.86% 71.75	72.37	76.24	75.76	89.08
Interest Income/Expense	1.23% 1.395	1.378	1.336	-	-
Benefits Costs and Expenses	0.15% 71.95	72.06	75.97	74.79	88.54
Costs And Expenses	0.44% 71.75	72.06	75.97	75.76	89.08
Depreciation and Amortization	0.67% 1.209	1.201	1.214	1.255	1.40
Operating Income/Loss	2.52% -69.61	-71.41	-75.02	-75.54	-84.62
Income/Loss From Continuing Operations Before Tax	1.82% -69.82	-71.11	-74.75	-74.57	-84.08
Income Tax Expense/Benefit	2,000% -0.019	0.001	0.022	0.002	0.01
Income/Loss From Continuing Operations After Tax	1.84% -69.80	-71.11	-74.77	-74.57	-84.09
Net Income/Loss	1.84% -69.80	-71.11	-74.77	-74.57	-84.09
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1.25% 106.40	105.09	103.97	0.40	102.42
Diluted Average Shares	1.25% 106.40	105.09	103.97	0.40	102.42
Basic Earnings Per Share	2.94% -0.66	-0.68	-0.72	-0.73	-0.82
Diluted Earnings Per Share	2.94% -0.66	-0.68	-0.72	-0.73	-0.82
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-